Global /Sweden /Healthcare /Medical Devices /BONEX
chevron_leftBack
Bonesupport Holding AB (publ) logo

Bonesupport Holding AB (publ)

BONEX
STO: BONEX Delayed
212.40SEK -2.3%
22.42 USD
As of 8 June 2026, Bonesupport Holding AB (publ) has a market cap of $1.51B USD, ranking #8365 globally and #103 in Sweden. It ranks #706 in the Healthcare sector, and #138 in the Medical Devices industry.
Global Rank
8365
Country Rank
103
Sector Rank
706
Industry Rank
138
Key Stats
Market Cap
$1.51BUSD
14.32B SEK
Enterprise Value
$1.46BUSD
13.88B SEK
Revenue (TTM)
$128.38MUSD
1.22B SEK
EBITDA (TTM)
$34.01MUSD
322.18M SEK
Net Income (TTM)
$19.56MUSD
185.11M SEK
EBITDA Margin
27%
Profit Margin
15%
PE Ratio
78.5
Forward PE
40.4
PS Ratio
11.8
PB Ratio
15.2
EV/EBITDA
42.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Torbjorn Skold open_in_new
Employees
160
Founded
1999
Website
bonesupport.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-2.3% -17% 14% 15% -6.5% -29%

News

Loading...

Markets

Exchange Ticker Price
Nasdaq Stockholm
MIC: XSTO
PRIMARY
BONEX
Bonesupport Holding AB
ISIN: SE0009858152
Shares Out.:
65.859M1 Shares Float: 56.293M2
TV:
SA:
YF:
GF:
BA:
MS:
212.40 SEK
London Stock Exchange
MIC: XLON
0RQO
Bonesupport Holding AB
ISIN: SE0009858152
TV:
SA:
YF:
GF:
BA:
MS:
213.50 SEK
Frankfurt Stock Exchange
MIC: XFRA
2B4
Bonesupport Holding AB
ISIN: SE0009858152
TV:
SA:
YF:
GF:
BA:
2B4
MS:
19.60 EUR
Show all 4 markets
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Bonesupport Holding AB (publ)

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also offers CERAMENT Bead Tray, an adjunctive local delivery option for surgeons for targeted delivery to osseous defects and for dead space management. In addition, the company develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, and foot and ankle surgery. Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.

Similar Companies

Industry: Medical Devices (Sweden)
Name
Market Cap diff.
PE
GETI-B
$5.54B
52.4B SEK
266%
22.2
EKTA-B
$2.2B
20.86B SEK
46%
-
$1.57B
14.87B SEK
3.9%
-
$898.55M
8.5B SEK
-41%
115.1
MCAP
$741.67M
7.02B SEK
-51%
31.9
$318.52M
3.01B SEK
-79%
22.5
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
$173.27B
11K%
25.8
$160.73B
11K%
56.7
$159.07B
10K%
25.6
DHR
$126.55B
8K%
34.7
SYK
$120.69B
8K%
38.3
MDT
$101.9B
7K%
22.2
chevron_leftBack